美国念珠菌血症流行病学变化:注射吸毒成为日益常见的危险因素(2014-2017年主动监测)
该研究在美国部分县开展基于人群的念珠菌血症主动监测。2017年共识别1191例12岁以上患者(发病率6.9/10万),其中128例(10.7%)有注射吸毒史,19-44岁患者中该比例高达34.6%。有注射吸毒史者更年轻,且较少具备典型危险因素,但吸烟、丙型肝炎和无家可归者比例更高。
要点
- 对缺乏典型危险因素的念珠菌血症患者,应考虑注射吸毒这一危险因素。
- 19-44岁且为社区获得性念珠菌血症者尤应警惕注射吸毒相关感染。
- 注射吸毒相关念珠菌血症患者中丙型肝炎和无家可归者比例明显升高。
核心结论
- 注射吸毒是美国念珠菌血症日益常见的危险因素,尤其在19-44岁人群和社区获得性感染者中。
- 临床医生对缺乏典型危险因素的念珠菌血症患者应考虑注射吸毒史。
研究设计与样本
- 在美国部分县开展基于人群的念珠菌血症主动监测,分析2014-2017年病例。
- 2017年识别1191例年龄>12岁的念珠菌血症病例,其中128例(10.7%)有注射吸毒史。
主要发现
- 2017年念珠菌血症发病率为6.9/10万人口。
- 有注射吸毒史者中位年龄35岁,无者为63岁(P < .001)。
- 有注射吸毒史者恶性肿瘤(7.0% vs 29.4%;RR,0.2 [95% CI,.1-.5])、腹部手术(3.9% vs 17.5%;RR,0.2 [95% CI,.09-.5])和全肠外营养(3.9% vs 22.5%;RR,0.2 [95% CI,.07-.4])比例更低。
- 有注射吸毒史者吸烟(68.8% vs 18.5%;RR,3.7 [95% CI,3.1-4.4])、丙型肝炎(54.7% vs 6.4%;RR,8.5 [95% CI,6.5-11.3])和无家可归(13.3% vs 0.8%;RR,15.7 [95% CI,7.1-34.5])比例更高。
- 19-44岁念珠菌血症患者中有注射吸毒史者占34.6%。
临床怎么用
- 对缺乏典型危险因素的念珠菌血症患者应主动询问注射吸毒史。
- 对19-44岁社区获得性念珠菌血症患者应警惕注射吸毒相关感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Injection drug use (IDU) is a known, but infrequent risk factor on candidemia; however, the opioid epidemic and increases in IDU may be changing the epidemiology of candidemia. METHODS: Active population-based surveillance for candidemia was conducted in selected US counties. Cases of candidemia were categorized as IDU cases if IDU was indicated in the medical records in the 12 months prior to the date of initial culture. RESULTS: During 2017, 1191 candidemia cases were identified in patients aged >12 years (incidence: 6.9 per 100 000 population); 128 (10.7%) had IDU history, and this proportion was especially high (34.6%) in patients with candidemia aged 19-44. Patients with candidemia and IDU history were younger than those without (median age, 35 vs 63 years; P < .001). Candidemia cases involving recent IDU were less likely to have typical risk factors including malignancy (7.0% vs 29.4%; relative risk [RR], 0.2 [95% confidence interval {CI}, .1-.5]), abdominal surgery (3.9% vs 17.5%; RR, 0.2 [95% CI, .09-.5]), and total parenteral nutrition (3.9% vs 22.5%; RR, 0.2 [95% CI, .07-.4]). Candidemia cases with IDU occurred more commonly in smokers (68.8% vs 18.5%; RR, 3.7 [95% CI, 3.1-4.4]), those with hepatitis C (54.7% vs 6.4%; RR, 8.5 [95% CI, 6.5-11.3]), and in people who were homeless (13.3% vs 0.8%; RR, 15.7 [95% CI, 7.1-34.5]). CONCLUSIONS: Clinicians should consider injection drug use as a risk factor in patients with candidemia who lack typical candidemia risk factors, especially in those with who are 19-44 years of age and have community-associated candidemia.
引用
- Zhang AY, Shrum S, Williams S, et al. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor-Active Surveillance in Selected Sites, United States, 2014-2017. Clin Infect Dis. 2020. PMID: 31676903. doi:10.1093/cid/ciz1061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。